Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-15-008502
Filing Date
2015-11-12
Accepted
2015-11-12 16:47:31
Documents
4
Period of Report
2015-10-16
Effectiveness Date
2015-11-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a1015_actiniumpharma.htm DEF 14A 846062
2 GRAPHIC image003.jpg GRAPHIC 49304
3 GRAPHIC image001.jpg GRAPHIC 21550
4 GRAPHIC image002.jpg GRAPHIC 67435
  Complete submission text file 0001213900-15-008502.txt   1038004
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36374 | Film No.: 151225491
SIC: 2834 Pharmaceutical Preparations